Menu
Montecito
American Riviera
Loading...
You are here:  Home  >  'Thousand Oaks'  -  Page 100
Latest

Op/ed: Maintaining the talent flow — How to retain your best workers

By   /  Friday, November 29th, 2013  /  Op/Eds, Opinion  /  Comments Off on Op/ed: Maintaining the talent flow — How to retain your best workers

The ever-increasing focus on the effective management of people, especially those who are key to an organization’s success, is one of the most important developments in management in the past 15 years. Starting with a seminal McKinsey study in 1998 and the authors’ 2001 book “The War for Talent,” the field of talent management has gained much respect and attention from scholars and practitioners across industries and national boundaries.

Read More →
Latest

Thousand Oaks cancer drug firm raises $9M

By   /  Friday, November 15th, 2013  /  Central Coast Health Watch, Technology, Top Stories  /  Comments Off on Thousand Oaks cancer drug firm raises $9M

Thousand Oaks-based ImmunGene, a cancer treatment firm led by a former Amgen scientist, has raised $9 million from Ally Bridge Group, an investment group with ties to Hong Kong.

ImmunGene’s so-called antibody-cytokine fusion technology could help improve the cancer-cell targeting in therapies. President and CEO Sanjay D. Khare was formerly the scientific director at Amgen, the biotech giant. Prior to the funding, ImmunGene had received several hundred thousand dollars in federal research grants.

Antibody technologies hold promise for creating cancer treatments that do less damage to healthy cells. Molecules are crafted to mimic the body’s own immune system and bind to specific defects in cancer cells.

Read More →
Latest

ImmunGene raises $9M

By   /  Thursday, November 7th, 2013  /  East Ventura County, Technology, Top Stories  /  Comments Off on ImmunGene raises $9M

Thousand Oaks-based ImmunGene, a cancer treatment firm led by a former Amgen scientist, has raised $9 million from Ally Bridge Group, an investment group with ties to Hong Kong.

ImmunGene’s so-called antibody-cytokine fusion technology could help improve the cancer-cell targeting in therapies. President and CEO Sanjay D. Khare was formerly the scientific director at Amgen, the biotech giant. Prior to the funding, ImmunGene had received several hundred thousand dollars in federal research grants.

Read More →
Latest

2014 Amgen Tour set to cycle through four of region’s cities

By   /  Tuesday, November 5th, 2013  /  Central Coast, East Ventura County, South Coast, Tourism, Tri-County Economy  /  Comments Off on 2014 Amgen Tour set to cycle through four of region’s cities

The 2014 Amgen Tour of California, the largest cycling race in the U.S., will visit four cities in the Tri-Counties in May. The eight-day annual event will roll through Cambria, Pismo Beach and Santa Barbara before concluding at the finish line in Thousand Oaks.

Read More →
Latest

Amgen profits leap in third quarter

By   /  Tuesday, October 22nd, 2013  /  Banking & Finance, Earnings, Latest news, Tri-County Public Companies  /  Comments Off on Amgen profits leap in third quarter

Shares of Thousand Oaks-based Amgen climbed past the $117 mark in after-hours trading Oct. 22 as third-quarter results blew through analyst forecasts with profits rising 24 percent. The world’s biggest biotech company reported a profit of $1.37 billion, or $1.79 per share, on revenue of $4.75 billion. Analysts were forecasting revenue of $4.6 billion and Read More →

Read More →
Latest

Gov. Brown vetoes Amgen-backed anti-biosimilars bill

By   /  Friday, October 18th, 2013  /  Banking & Finance, Central Coast Health Watch, Technology, Top Stories, Tourism, Tri-County Public Companies  /  Comments Off on Gov. Brown vetoes Amgen-backed anti-biosimilars bill

Gov. Jerry Brown vetoed a bill supported by Thousand Oaks-based Amgen and other biotechnology companies that would have made it more difficult for pharmacists to dispense so-called biosimilars, the biotech industry’s analogue to generic pharmaceuticals.

Senate Bill 598, approved by both houses of the legislature, looked mostly like a procedural change to state’s pharmacy laws. If it passed, the bill would have allowed pharmacists to fill prescriptions with biosimilars that the U.S. Food and Drug Administration deems “interchangeable” with brand-name counterparts.

Read More →
Latest

Bottle it up: Vapur exec, daughter team to put filling stations in schools

By   /  Friday, September 27th, 2013  /  Features, Small Business  /  Comments Off on Bottle it up: Vapur exec, daughter team to put filling stations in schools

Kathryn Reinke had the idea to team up with her father’s water bottle company, Westlake Village-based Vapur, to raise money to install new fountains that would have cold, filtered water in addition to a “filling station” feature that would let students easily refill reusable water bottles.

Read More →